Exome Asset Management

Exome Asset Management offers strategic investing in healthcare companies throughout the world, with an emphasis on the United States and other developed countries. Exome Asset Management is a culturally diverse, innovative asset management company focusing on investing in public markets across the worldwide healthcare industry, including pharmaceuticals, biotechnology, healthcare services, and medical devices. Exome employs sound investment strategies and a philosophy developed by Samuel D. Isaly, who has spent the majority of his 45-year career focused on both developed and emerging markets healthcare. Sam Isaly is an experienced healthcare fund manager and has been active in global healthcare investing and analysis for nearly five decades. Diversity is fundamental to worldwide investing. As such, Exome employs a staff of diverse investment professionals and support staff committed to investing in a healthier world.